PDX Select
Model Bank
Search through our extensive and highly characterized PDX bank.
1393 models
page 49 of 59
CTG-3541
Rectal
Adenocarcinoma
Tumor status
Not available
Treatment history
Pretreated
Harvest site
Rectum
Disease stage
Not Available
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3544
Breast
Invasive ductal carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Supraclavicular Lymph Node
Disease stage
II
Lumin data
RNA-Seq, WES
View model →
CTG-3546
Colorectal
Mucinous adenocarcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Abdomen
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-3547
Head and neck
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Mouth
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3565
Head and neck
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Larynx
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3569
NSCLC
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Pending
Disease stage
Pending
Lumin data
RNA-Seq, WES
View model →
CTG-3574
NSCLC
Squamous cell carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Brain
Disease stage
Pending
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3579
Colorectal
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Liver
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-3580
Head and neck
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Mouth
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3581
Prostate
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Brain
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3582
Medulloblastoma
Adenocarcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Brain
Disease stage
Pending
Lumin data
RNA-Seq, WES
View model →
CTG-3604
Colorectal
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Liver
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-3606
Breast
Invasive ductal carcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Breast
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3608
Uterine
Serous carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Abdomen Fluid
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-3610
Prostate
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Lymph Node
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3615
Head and neck
Squamous cell carcinoma
Tumor status
Local metastatic
Treatment history
Naive
Harvest site
Bone
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3628
Ovarian
Mucinous adenocarcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Ovary
Disease stage
Pending
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3629
Rectal
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Rectum
Disease stage
II
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3631
Colorectal
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Liver
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3651
NSCLC
Carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Adrenal Gland
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3660
Acute myeloid leukemia (AML)
Treatment history
Pretreated
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3661
Acute myeloid leukemia (AML)
Treatment history
Pretreated
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3674
Acute myeloid leukemia (AML)
Treatment history
Pretreated
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-3679
Acute myeloid leukemia (AML)
Treatment history
Naive
Lumin data
RNA-Seq, WES, Proteomics
View model →
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.